Journal of Parasite Research

Edwin Too, Research officer,
Kenya Medical Research Institute,
Centre for Biotechnology Research and Development
Editorial Board

Edwin Too

Research officer, Kenya Medical Research Institute, Centre for Biotechnology Research and Development · Nigeria

Editorial leadership for Journal of Parasite Research ISSN 2690-6759

Research interests

  • Assessment Of Therapeutic Efficacy To The Antifolates
  • Artemisinin
  • Non-Artemisinin Based Combinations Against Falciparum Malaria. Molecular Characterization
  • Application Of Radionuclide Techniques For The Detection Of Drug-Resistant Malaria Parasites. Monitoring Of Antimalarial Drug Efficacy Using Quantitative Assays
  • E.g Nucleic Acid Sequence-Based Amplification (Qt-Nasba)
  • Rt-Pcr. Transmission Dynamics Studies Post-Artemisinin-Based Intervention. Parasite Population Studies Determining Origin
  • Dispersal Mechanisms Of Resistant Parasites. Human Population Studies Investigating Protection To Malaria Disease
  • Prevalence Of Some Human Immune Genes
  • Other Phenotypic Markers. Diagnosis Of Malaria Parasites. In Vitro Screening Of Traditional Medicines For Antimalarial Activity
  • Towards Bio-Prospecting For Antimalarial Agents

Biography

Publications:

  1. Evaluation of Efficacy of Artemether Lumefantrine and Dihydro-Artemisinin Piperaquine in Clearance of Gametocytes in Uncomplicated Plasmodium Falciparum Malaria and Effectiveness of Microscopy and Rt-Pcr in Gametocytes Detection. 
  2. PfEMP1 DBLα Sequence Tags in Genomic DNA of P. falciparum Field Isolates from Two Malaria Endemic Sites in Kenya.
  3. In Vivo Anti-malarial Test of Essential Oil Extracted from Nigella sativa (L.) Seeds‟. The   Journal of Ethnopharmacology. Sabah O mar, Rahma U. Yusuf, Edwin Too. (2009).

Considering JPAR for your work?

This journal is guided by Edwin Too (Research officer, Kenya Medical Research Institute, Centre for Biotechnology Research and Development) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu